Abstract | BACKGROUND:
Monocyte chemotactic protein 1 (MCP-1) plays an important role in various immune and allergic disorders since it is a potent chemo-attractant for inflammatory cells, such as eosinophils, memory T cells, and monocytes. OBJECTIVE: METHODS: In this longitudinal cohort design study, sequential serum levels of MCP-1 were measured by a sandwich enzyme-linked immunosorbent assay (ELISA). Twenty-four asthma patients' MCP-1 levels were examined at 5 time points: during the asymptomatic phase, in an acute wheezing episode, and at 1 week, 1 month, and 2 months after acute asthma attack. Fifteen children without asthma were enrolled as control. RESULTS: During the asymptomatic phase of asthma, serum MCP-1 levels were significantly higher than that of normal controls (329.57 +/- 99.20 pg/ml vs. 213.63 +/- 77.29 pg/ml, p = 0.001). In comparison with the asymptomatic phase, the serum MCP-1 levels during the acute asthma attack were significantly higher (682.88 +/- 88.45 pg/ml vs. 329.57 +/- 99.20 pg/ml, p < 0.001). After treatment of acute asthma exacerbation, all of the serum MCP-1 levels declined within 1 week, but were still higher than control 2 months later. CONCLUSION: In asthma patients, the consistently elevated serum levels of MCP-1 suggest its role in the pathogenesis of bronchial asthma - not only in the chronic inflammatory processes, but also in acute asthma attack exacerbation. These findings suggest a possible role for MCP-1 in the pathogenesis of asthma and a potential role for its use in anti- asthma treatment in the future.
|
Authors | Chin-Kan Chan, Ming-Ling Kuo, Kuo-Wei Yeh, Liang-Shiou Ou, Li-Chen Chen, Tsung-Chieh Yao, Jing-Long Huang |
Journal | The Journal of asthma : official journal of the Association for the Care of Asthma
(J Asthma)
Vol. 46
Issue 3
Pg. 225-8
(Apr 2009)
ISSN: 1532-4303 [Electronic] England |
PMID | 19373627
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Androstadienes
- Bronchodilator Agents
- Chemokine CCL2
- Fluticasone
- Terbutaline
|
Topics |
- Acute Disease
- Adolescent
- Androstadienes
(therapeutic use)
- Asthma
(blood, drug therapy)
- Bronchodilator Agents
(therapeutic use)
- Chemokine CCL2
(biosynthesis, blood)
- Child
- China
- Enzyme-Linked Immunosorbent Assay
- Female
- Fluticasone
- Humans
- Longitudinal Studies
- Male
- Respiratory Function Tests
- Terbutaline
(therapeutic use)
|